Knowledge Center
Article / Jan 01, 2004
Selecting lactose for a capsule-based dry powder inhaler
Source:
Pharmaceutical Technology Europe (2004), 16(4), 23
Dry powder inhalers are a well-accepted dosage form for pulmonary drug delivery and a wide variety are either currently available or development. This article examines a premetered, capsule-based multidose inhaler for which different qualities of _-lactose monohydrate were screened.
Also in the Knowledge Center
/ Feb 24, 2021
Webinar - Computational Methods and High Throughput Screening in the Formulation of ASDs
Read more
Scientific Article
/ Feb 12, 2021
Webinar - From Lab to Commercial: Fully Integrated Solutions for Dry Powder Inhalation
Read more
Scientific Article
/ Feb 02, 2022
Webinar - Process safety evaluation and scale-up resorting to mechanistic modelling for exothermic and gas releasing reactions
Read more
Scientific Article